title: Management options for persistent postoperative acromegaly.
abstract: This article presents management options for the patient with acromegaly after noncurative surgery. The current evidence for repeat surgery, adjuvant medical therapy with somatostatin analogues, dopamine agonists, the growth hormone receptor antagonist pegvisomant, combination medical therapy, and radiotherapy in the context of persistent postoperative disease are summarized. The relative advantages and disadvantages of each of these treatment modalities are explored, and a general treatment algorithm that integrates these modalities is proposed.
authors.affiliation: Johns Hopkins University School of Medicine, Division of Endocrinology & Metabolism, Department of Medicine, Baltimore, MD 21287, USA.
authors.forename: Nestoras
authors.initials: N
authors.lastname: Mathioudakis
authors.forename: Roberto
authors.initials: R
authors.lastname: Salvatori
mesh_terms: D000172:Acromegaly / Q000628:therapy*; D003131:Combined Modality Therapy; D019382:Human Growth Hormone / Q000378:metabolism; D006801:Humans; D010911:Pituitary Neoplasms / Q000628:therapy*; D011184:Postoperative Period
chemical_list: D019382:Human Growth Hormone